Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better

被引：15
作者：
Bossi, Paolo [1 ,2 ]
Gurizzan, Cristina [3 ]
Chan, Anthony [4 ]
机构：
[1] IRCCS Humanitas Res Hosp, Dept Biomed Sci, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Milan, Italy
[3] Univ Brescia, ASST Spedali Civili, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth,Med Oncol, Brescia, Italy
[4] Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 20期
关键词：
1ST-LINE TREATMENT; PLUS CHEMOTHERAPY; RECURRENT; MULTICENTER; TORIPALIMAB;
D O I：
10.1001/jama.2023.22465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1954 / 1955
页数：2
相关论文
共 12 条
[11]   Epstein-Barr virus and nasopharyngeal carcinoma [J].
Young, Lawrence S. ;
Dawson, Christopher W. .
CHINESE JOURNAL OF CANCER, 2014, 33 (12) :581-590
[12]   Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment [J].
Zou, Xiong ;
You, Rui ;
Liu, Huai ;
He, Yu-Xiang ;
Xie, Guo-Feng ;
Xie, Zhi-Hai ;
Li, Ji-Bin ;
Jiang, Rou ;
Liu, Li-Zhi ;
Li, Li ;
Zhang, Meng-Xia ;
Liu, You-Ping ;
Hua, Yi-Jun ;
Guo, Ling ;
Qian, Chao-Nan ;
Mai, Hai-Qiang ;
Chen, Dong-Ping ;
Luo, Ying ;
Shen, Liang-Fang ;
Hong, Ming-Huang ;
Chen, Ming-Yuan .
EUROPEAN JOURNAL OF CANCER, 2017, 77 :117-126
12